• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Rebate Walls Stifle Prescription Drug Competition

cafead

Administrator
Staff member
  • cafead   Mar 01, 2021 at 11:02: AM
via Rebate walls are exclusionary contracting practices that a drug manufacturer deploys to limit the ability of rivals from gaining preferred access to the formulary, or any access at all. As such, they limit the uptake of biosimilars, (specialty) generics, and branded competitors.

article source